APA (7th ed.) Citation

RL, M., LP, W., CHV, N. F., LA, R., PA, V., MA, L., . . . RM, C. (2019). Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma. Cellular oncology (Dordrecht, Netherlands), 42(2), 143. https://doi.org/10.1007/s13402-018-0416-2

Chicago Style (17th ed.) Citation

RL, Markman, et al. "Interfering with Bromodomain Epigenome Readers as Therapeutic Option in Mucoepidermoid Carcinoma." Cellular Oncology (Dordrecht, Netherlands) 42, no. 2 (2019): 143. https://doi.org/10.1007/s13402-018-0416-2.

MLA (9th ed.) Citation

RL, Markman, et al. "Interfering with Bromodomain Epigenome Readers as Therapeutic Option in Mucoepidermoid Carcinoma." Cellular Oncology (Dordrecht, Netherlands), vol. 42, no. 2, 2019, p. 143, https://doi.org/10.1007/s13402-018-0416-2.